During the past decade, IU Health La Porte Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 79 clinical trials were completed, i.e. on average, 1975% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 29 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IU Health La Porte Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 63 trials, followed by "Gynecologic Oncology Group" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored and "GOG Foundation" with 6 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IU Health La Porte Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 37 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "IU Health La Porte Hospital" are "Recurrent Breast Carcinoma" (8 trials), "Stage IV Fallopian Tube Cancer AJCC v6 and v7" (8 trials), "Stage IV Ovarian Cancer AJCC v6 and v7" (8 trials), "Ovarian Endometrioid Adenocarcinoma" (7 trials) and "Ovarian Serous Adenocarcinoma" (7 trials). Many other conditions were trialed in "IU Health La Porte Hospital" in a lesser frequency.

Most popular intervention types in "IU Health La Porte Hospital" are "Drug" (88 trials), "Other" (75 trials), "Biological" (44 trials), "Procedure" (16 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (56 trials), "Quality-of-Life Assessment" (35 trials), "Paclitaxel" (27 trials), "Bevacizumab" (22 trials) and "Carboplatin" (22 trials). Other intervention names were less common.

The vast majority of trials in "IU Health La Porte Hospital" are 57 trials for "All" genders, 42 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "IU Health La Porte Hospital". undefined are not yet recruiting, 1 are recruiting, 45 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in IU Health La Porte Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in IU Health La Porte Hospital, 4 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

IU Health La Porte Hospital has several departments that took part in Clinical trials: "Center for Cancer Therapy at LaPorte Hospital and Health Services" - 128 trials